BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10450086)

  • 1. Dynamical properties of fasciculin-2.
    Baker NA; Helms V; McCammon JA
    Proteins; 1999 Sep; 36(4):447-53. PubMed ID: 10450086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.
    Bui JM; Radic Z; Taylor P; McCammon JA
    Biophys J; 2006 May; 90(9):3280-7. PubMed ID: 16473897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation.
    Tai K; Shen T; Henchman RH; Bourne Y; Marchot P; McCammon JA
    J Am Chem Soc; 2002 May; 124(21):6153-61. PubMed ID: 12022850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom.
    Marchot P; Prowse CN; Kanter J; Camp S; Ackermann EJ; Radić Z; Bougis PE; Taylor P
    J Biol Chem; 1997 Feb; 272(6):3502-10. PubMed ID: 9013597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin.
    Marchot P; Bourne Y; Prowse CN; Bougis PE; Taylor P
    Toxicon; 1998 Nov; 36(11):1613-22. PubMed ID: 9792178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.
    van den Born HK; Radić Z; Marchot P; Taylor P; Tsigelny I
    Protein Sci; 1995 Apr; 4(4):703-15. PubMed ID: 7613468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterase: enhanced fluctuations and alternative routes to the active site in the complex with fasciculin-2.
    Bui JM; Tai K; McCammon JA
    J Am Chem Soc; 2004 Jun; 126(23):7198-205. PubMed ID: 15186156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target.
    Harel M; Kleywegt GJ; Ravelli RB; Silman I; Sussman JL
    Structure; 1995 Dec; 3(12):1355-66. PubMed ID: 8747462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein complex formation by acetylcholinesterase and the neurotoxin fasciculin-2 appears to involve an induced-fit mechanism.
    Bui JM; McCammon JA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15451-6. PubMed ID: 17021015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciculin: modification of carboxyl groups and discussion of structure-activity relationship.
    Cerveñansky C; Durán R; Karlsson E
    Toxicon; 1996 Jun; 34(6):718-21. PubMed ID: 8817817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.
    Kryger G; Harel M; Giles K; Toker L; Velan B; Lazar A; Kronman C; Barak D; Ariel N; Shafferman A; Silman I; Sussman JL
    Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1385-94. PubMed ID: 11053835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex.
    Radić Z; Taylor P
    J Biol Chem; 2001 Feb; 276(7):4622-33. PubMed ID: 11036076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1.9-A resolution structure of fasciculin 1, an anti-acetylcholinesterase toxin from green mamba snake venom.
    le Du MH; Marchot P; Bougis PE; Fontecilla-Camps JC
    J Biol Chem; 1992 Nov; 267(31):22122-30. PubMed ID: 1429564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex.
    Bourne Y; Taylor P; Marchot P
    Cell; 1995 Nov; 83(3):503-12. PubMed ID: 8521480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site of fasciculin interaction with acetylcholinesterase.
    Radić Z; Duran R; Vellom DC; Li Y; Cervenansky C; Taylor P
    J Biol Chem; 1994 Apr; 269(15):11233-9. PubMed ID: 8157652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR and restrained molecular dynamics study of the three-dimensional solution structure of toxin FS2, a specific blocker of the L-type calcium channel, isolated from black mamba venom.
    Albrand JP; Blackledge MJ; Pascaud F; Hollecker M; Marion D
    Biochemistry; 1995 May; 34(17):5923-37. PubMed ID: 7727450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron paramagnetic resonance reveals altered topography of the active center gorge of acetylcholinesterase after binding of fasciculin to the peripheral site.
    Sentjurc M; Pecar S; Stojan J; Marchot P; Radić Z; Grubic Z
    Biochim Biophys Acta; 1999 Mar; 1430(2):349-58. PubMed ID: 10082962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-bonding interactions in the binding of loop 1 of fasciculin 2 to Torpedo californica acetylcholinesterase: a density functional theory study.
    Wang J; Gu J; Leszczynski J
    J Phys Chem B; 2005 Jul; 109(28):13761-9. PubMed ID: 16852724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble monomeric acetylcholinesterase from mouse: expression, purification, and crystallization in complex with fasciculin.
    Marchot P; Ravelli RB; Raves ML; Bourne Y; Vellom DC; Kanter J; Camp S; Sussman JL; Taylor P
    Protein Sci; 1996 Apr; 5(4):672-9. PubMed ID: 8845756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
    Rosenberry TL; Rabl CR; Neumann E
    Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.